Reed Smith’s Life Sciences Health Industry Group will be hosting an upcoming CLE webinar, “The Good, the Bad and the Ugly: The Best and Worst Drug/Medical Device Decisions of 2016” on Wednesday, January 18, 2017 at 12 p.m. ET.
Each year since 2007, James Beck, Reed Smith’s Senior Life Sciences Policy Analyst and the founder of the popular Drug and Device Law blog, has compiled and posted lists of the 10 best and 10 worst drug and medical device court decisions for that year, with the input of his fellow Drug and Device Law bloggers. These cases are selected based on their likely precedential value, their importance to drug and device manufacturers, and their inherent (and subjective) merit.
In this webinar, James – along with Reed Smith partners and fellow Drug and Device Law bloggers Eric Alexander and Steven Boranian — will explain the significance, whether good or bad, of each case and provide insight into how the cases will likely be influential in the future.
This program is free and presumptively approved for 1.5 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.5 credit under New York’s Approved Jurisdiction Policy.
You can register by clicking here.